Edited By: Masayuki Kurosaki
Journal list menu
Hepatology Research is the official journal of the Japan Society of Hepatology, devoted to publishing human and animal studies, both basic and clinical, in the field of hepatology. We welcome submissions of original articles, experimental, clinical, reviews, short communications, and letters to the editors.
Articles
Refining the predictive utility of aspartate aminotransferase to platelet ratio index in nonalcoholic fatty liver disease patients with COVID‐19
-  7 November 2024
Distinct characteristics of MetALD (metabolic dysfunction‐associated steatotic liver disease with greater alcohol consumption) in the general population
-  5 November 2024
Graphical Abstract
MetALD is a new terminology for patients with MASLD consuming significant but moderate amount of alcohol. MetALD is on the spectrum of steatotic liver disease, but it is not known whether it is similar to either of MASLD or ALD in its characteristics. MetALD exhibited distinct characteristics from MASLD in terms of higher daily total energy and fat intake, and worse cardiometabolic risk factors except for hyperHDL-cholesterolemia - rather similar to those of alcohol related liver disease.
Unveiling the dynamics of hepatitis C virus transmission among injection drug users and men who have sex with men: A comprehensive study in Japan
-  4 November 2024
Diagnostic accuracy of hepatitis E virus antibody tests: A comprehensive meta‐analysis
-  2 November 2024
Risk model for predicting failure to rescue after hepatectomy: Cohort study of 1371 consecutive patients
-  2 November 2024
Graphical Abstract
The following is a list of the most cited articles based on citations published in the last three years, according to CrossRef.
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update
-  1109-1113
-  23 July 2019
Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria
-  951-963
-  2 August 2016
Comparison of FIB‐4 index, NAFLD fibrosis score and BARD score for prediction of advanced fibrosis in adult patients with non‐alcoholic fatty liver disease: A meta‐analysis study
-  862-870
-  13 January 2016
MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: Generalized estimating equation approach
-  1115-1128
-  15 June 2021
Evidence‐based clinical practice guidelines for liver cirrhosis 2020
-  725-749
-  6 July 2021